 | • レポートコード：GIR201100758 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アプレピタントの世界市場を調査対象にし、アプレピタントの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（注射、経口）、用途別分析（病院、ドラッグストア）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Merck & Co.、Glenmark Pharmaceuticals、Heron Therapeutics、Sandoz ・メーカー別販売量、売上、市場シェア ・アプレピタントの地域別市場分析 ・アプレピタントの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アプレピタントのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アプレピタントのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アプレピタントの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アプレピタントの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アプレピタントの種類別市場規模2015-2020：注射、経口 ・アプレピタントの用途別市場規模2015-2020：病院、ドラッグストア ・アプレピタントの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Aprepitant market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Aprepitant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Aprepitant market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Aprepitant market has been segmented into
Injection
Oral
By Application, Aprepitant has been segmented into:
Hospital
Drug store
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Aprepitant market presented in the report. This section sheds light on the sales growth of different regional and country-level Aprepitant markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Aprepitant market.
The report offers in-depth assessment of the growth and other aspects of the Aprepitant market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Aprepitant Market Share Analysis
Aprepitant competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Aprepitant sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Aprepitant sales, revenue and market share for each player covered in this report.
The major players covered in Aprepitant are:
Merck & Co.
Glenmark Pharmaceuticals
Heron Therapeutics
Sandoz
Among other players domestic and global, Aprepitant market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aprepitant product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Aprepitant, with price, sales, revenue and global market share of Aprepitant in 2018 and 2019.
Chapter 3, the Aprepitant competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aprepitant breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Aprepitant market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Aprepitant sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Aprepitant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Aprepitant Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Injection
1.2.3 Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Aprepitant Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug store
1.4 Overview of Global Aprepitant Market
1.4.1 Global Aprepitant Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck & Co. SWOT Analysis
2.1.4 Merck & Co. Product and Services
2.1.5 Merck & Co. Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Glenmark Pharmaceuticals
2.2.1 Glenmark Pharmaceuticals Details
2.2.2 Glenmark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Glenmark Pharmaceuticals SWOT Analysis
2.2.4 Glenmark Pharmaceuticals Product and Services
2.2.5 Glenmark Pharmaceuticals Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Heron Therapeutics
2.3.1 Heron Therapeutics Details
2.3.2 Heron Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Heron Therapeutics SWOT Analysis
2.3.4 Heron Therapeutics Product and Services
2.3.5 Heron Therapeutics Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sandoz SWOT Analysis
2.4.4 Sandoz Product and Services
2.4.5 Sandoz Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Aprepitant Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Aprepitant Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Aprepitant Manufacturer Market Share in 2019
3.3.2 Top 6 Aprepitant Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Aprepitant Sales, Revenue and Market Share by Regions
4.1.1 Global Aprepitant Sales and Market Share by Regions (2015-2020)
4.1.2 Global Aprepitant Revenue and Market Share by Regions (2015-2020)
4.2 North America Aprepitant Sales and Growth Rate (2015-2020)
4.3 Europe Aprepitant Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Aprepitant Sales and Growth Rate (2015-2020)
4.5 South America Aprepitant Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Aprepitant Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Aprepitant Sales, Revenue and Market Share by Country
5.1.1 North America Aprepitant Sales and Market Share by Country (2015-2020)
5.1.2 North America Aprepitant Revenue and Market Share by Country (2015-2020)
5.2 United States Aprepitant Sales and Growth Rate (2015-2020)
5.3 Canada Aprepitant Sales and Growth Rate (2015-2020)
5.4 Mexico Aprepitant Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Aprepitant Sales, Revenue and Market Share by Country
6.1.1 Europe Aprepitant Sales and Market Share by Country (2015-2020)
6.1.2 Europe Aprepitant Revenue and Market Share by Country (2015-2020)
6.2 Germany Aprepitant Sales and Growth Rate (2015-2020)
6.3 UK Aprepitant Sales and Growth Rate (2015-2020)
6.4 France Aprepitant Sales and Growth Rate (2015-2020)
6.5 Russia Aprepitant Sales and Growth Rate (2015-2020)
6.6 Italy Aprepitant Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Aprepitant Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Aprepitant Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Aprepitant Revenue and Market Share by Regions (2015-2020)
7.2 China Aprepitant Sales and Growth Rate (2015-2020)
7.3 Japan Aprepitant Sales and Growth Rate (2015-2020)
7.4 Korea Aprepitant Sales and Growth Rate (2015-2020)
7.5 India Aprepitant Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Aprepitant Sales and Growth Rate (2015-2020)
7.7 Australia Aprepitant Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Aprepitant Sales, Revenue and Market Share by Country
8.1.1 South America Aprepitant Sales and Market Share by Country (2015-2020)
8.1.2 South America Aprepitant Revenue and Market Share by Country (2015-2020)
8.2 Brazil Aprepitant Sales and Growth Rate (2015-2020)
8.3 Argentina Aprepitant Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Aprepitant Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Aprepitant Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Aprepitant Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Aprepitant Sales and Growth Rate (2015-2020)
9.3 Turkey Aprepitant Sales and Growth Rate (2015-2020)
9.4 Egypt Aprepitant Sales and Growth Rate (2015-2020)
9.5 South Africa Aprepitant Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Aprepitant Sales and Market Share by Type (2015-2020)
10.2 Global Aprepitant Revenue and Market Share by Type (2015-2020)
10.3 Global Aprepitant Price by Type (2015-2020)
11 Global Aprepitant Market Segment by Application
11.1 Global Aprepitant Sales Market Share by Application (2015-2020)
11.2 Global Aprepitant Revenue Market Share by Application (2015-2020)
11.3 Global Aprepitant Price by Application (2015-2020)
12 Market Forecast
12.1 Global Aprepitant Sales, Revenue and Growth Rate (2021-2025)
12.2 Aprepitant Market Forecast by Regions (2021-2025)
12.2.1 North America Aprepitant Market Forecast (2021-2025)
12.2.2 Europe Aprepitant Market Forecast (2021-2025)
12.2.3 Asia-Pacific Aprepitant Market Forecast (2021-2025)
12.2.4 South America Aprepitant Market Forecast (2021-2025)
12.2.5 Middle East & Africa Aprepitant Market Forecast (2021-2025)
12.3 Aprepitant Market Forecast by Type (2021-2025)
12.3.1 Global Aprepitant Sales Forecast by Type (2021-2025)
12.3.2 Global Aprepitant Market Share Forecast by Type (2021-2025)
12.4 Aprepitant Market Forecast by Application (2021-2025)
12.4.1 Global Aprepitant Sales Forecast by Application (2021-2025)
12.4.2 Global Aprepitant Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Aprepitant Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Aprepitant by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Aprepitant Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 8. Merck & Co. Aprepitant Major Business
Table 9. Merck & Co. Aprepitant Total Revenue (USD Million) (2018-2019)
Table 10. Merck & Co. SWOT Analysis
Table 11. Merck & Co. Aprepitant Product and Services
Table 12. Merck & Co. Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Glenmark Pharmaceuticals Aprepitant Major Business
Table 15. Glenmark Pharmaceuticals Aprepitant Total Revenue (USD Million) (2018-2019)
Table 16. Glenmark Pharmaceuticals SWOT Analysis
Table 17. Glenmark Pharmaceuticals Aprepitant Product and Services
Table 18. Glenmark Pharmaceuticals Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Heron Therapeutics Aprepitant Major Business
Table 21. Heron Therapeutics Aprepitant Total Revenue (USD Million) (2018-2019)
Table 22. Heron Therapeutics SWOT Analysis
Table 23. Heron Therapeutics Aprepitant Product and Services
Table 24. Heron Therapeutics Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sandoz Basic Information, Manufacturing Base and Competitors
Table 26. Sandoz Aprepitant Major Business
Table 27. Sandoz Aprepitant Total Revenue (USD Million) (2018-2019)
Table 28. Sandoz SWOT Analysis
Table 29. Sandoz Aprepitant Product and Services
Table 30. Sandoz Aprepitant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Aprepitant Sales by Manufacturer (2018-2019) (K Units)
Table 32. Global Aprepitant Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Aprepitant Sales by Regions (2015-2020) (K Units)
Table 34. Global Aprepitant Sales Market Share by Regions (2015-2020)
Table 35. Global Aprepitant Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Aprepitant Sales by Countries (2015-2020) (K Units)
Table 37. North America Aprepitant Sales Market Share by Countries (2015-2020)
Table 38. North America Aprepitant Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Aprepitant Revenue Market Share by Countries (2015-2020)
Table 40. Europe Aprepitant Sales by Countries (2015-2020) (K Units)
Table 41. Europe Aprepitant Sales Market Share by Countries (2015-2020)
Table 42. Europe Aprepitant Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Aprepitant Sales by Regions (2015-2020) (K Units)
Table 44. Asia-Pacific Aprepitant Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Aprepitant Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Aprepitant Sales by Countries (2015-2020) (K Units)
Table 47. South America Aprepitant Sales Market Share by Countries (2015-2020)
Table 48. South America Aprepitant Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Aprepitant Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Aprepitant Sales by Countries (2015-2020) (K Units)
Table 51. Middle East & Africa Aprepitant Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Aprepitant Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Aprepitant Revenue Market Share by Countries (2015-2020)
Table 54. Global Aprepitant Sales by Type (2015-2020) (K Units)
Table 55. Global Aprepitant Sales Share by Type (2015-2020)
Table 56. Global Aprepitant Revenue by Type (2015-2020) (USD Million)
Table 57. Global Aprepitant Revenue Share by Type (2015-2020)
Table 58. Global Aprepitant Sales by Application (2015-2020) (K Units)
Table 59. Global Aprepitant Sales Share by Application (2015-2020)
Table 60. Global Aprepitant Sales Forecast by Regions (2021-2025) (K Units)
Table 61. Global Aprepitant Market Share Forecast by Regions (2021-2025)
Table 62. Global Aprepitant Sales Forecast by Type (2021-2025) (K Units)
Table 63. Global Aprepitant Market Share Forecast by Type (2021-2025)
Table 64. Global Aprepitant Sales Forecast by Application (2021-2025)
Table 65. Global Aprepitant Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Aprepitant Picture
Figure 2. Global Sales Market Share of Aprepitant by Type in 2019
Figure 3. Injection Picture
Figure 4. Oral Picture
Figure 5. Aprepitant Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Aprepitant Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Aprepitant Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Aprepitant Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Aprepitant Sales Market Share by Manufacturer in 2019
Figure 29. Global Aprepitant Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Aprepitant Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Aprepitant Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Aprepitant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Aprepitant Revenue Market Share by Regions (2015-2020)
Figure 36. Global Aprepitant Revenue Market Share by Regions in 2018
Figure 37. North America Aprepitant Sales and Growth Rate (2015-2020)
Figure 38. Europe Aprepitant Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Aprepitant Sales and Growth Rate (2015-2020)
Figure 40. South America Aprepitant Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Aprepitant Sales and Growth Rate (2015-2020)
Figure 42. North America Aprepitant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Aprepitant Sales Market Share by Countries (2015-2020)
Figure 44. North America Aprepitant Sales Market Share by Countries in 2018
Figure 45. North America Aprepitant Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Aprepitant Revenue Market Share by Countries in 2018
Figure 47. United States Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Aprepitant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Aprepitant Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Aprepitant Revenue Market Share by Countries in 2019
Figure 53. Germany Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Aprepitant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Aprepitant Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Aprepitant Revenue Market Share by Regions 2019
Figure 61. China Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Aprepitant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Aprepitant Sales Market Share by Countries in 2019
Figure 68. South America Aprepitant Revenue Market Share by Countries in 2019
Figure 69. Brazil Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Aprepitant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Aprepitant Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Aprepitant Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Aprepitant Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Aprepitant Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Aprepitant Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Aprepitant Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Aprepitant Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Aprepitant Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Aprepitant Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Aprepitant Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Aprepitant Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
経口制御放出薬物送達技術の世界市場 2020年 Market Overview The global Oral Controlled Release Drug Delivery Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …- 経口輸液検査システムの世界市場 2020年 Market Overview The Oral Fluid Drug Test System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- イバンドロネートの世界市場 2020年 Market Overview The global Ibandronate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ibandronate market report provide…
- アンブリセンタン薬の世界市場 2020年 Market Overview The global Ambrisentan Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ambrisentan Drug market repo…
- タダラフィル経口の世界市場 2020年 Market Overview The global Tadalafil Oral market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tadalafil Oral market report p…